AASS 抗体 (AA 243-292)
Quick Overview for AASS 抗体 (AA 243-292) (ABIN2884780)
抗原
See all AASS 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 243-292
- 
                                            特异性
- AASS Antibodyantibody detects endogenous levels of AASS.
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide from human AASS (aa243-292).
 Type of Immunogen: Synthetic peptide
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C.
 
- 
                                            
- 
    - AASS (Aminoadipate Semialdehyde Synthase (AASS))
- 
                                            别名
- AASS / LKR / SDH
- 
                                            背景
- 
                        Name/Gene ID: AASS
 Synonyms: AASS, LKRSDH, LKR/SDH, LORSDH
- 
                                            基因ID
- 10157
- 
                                            UniProt
- Q9UDR5
- 
                                            途径
- SARS-CoV-2 Protein Interactome
 抗原
- 
                    
 
                                     
                                     
                                    